Shana Kelley, Pioneer in Translational Bioanalytical Research, Joining Northwestern Biomedical Engineering
Kelley, an internationally renowned researcher, will be jointly appointed in Biomedical Engineering and Chemistry
Shana Kelley, a pioneer in translational bioanalytical research, is joining Northwestern Engineering’s Department of Biomedical Engineering. An internationally renowned researcher who has developed innovative and translational methods for tracking molecular and cellular analytes with unprecedented sensitivity, Kelley is known for novel approaches to integrating nanoscience, bioanalytical science, and engineering.
Kelley will also have an appointment within the chemistry department of the Weinberg College of Arts and Sciences, and will be affiliated with the International Institute for Nanotechnology. She was previously a professor at the University of Toronto.
Kelley perfected a groundbreaking method for nucleic acid detection that uses high surface area nanoscale gold-based sensors. She is also well-known for developing new methods to detect circulating cancer cells and delivery systems that leverage mitochondrial penetrating peptides and related materials. Her most recent work has focused on developing high throughput omics approaches for the discovery and development of cell-based and molecular therapies.
A prolific author of academic papers, Kelley has earned numerous awards and distinctions, including the ACS Inorganic Nanoscience Award, the NSERC E.W.R. Steacie Fellowship, and an Alfred P. Sloan Fellowship. She is a fellow of the American Institute for Biological and Medical Engineers and the Royal Society of Canada. Kelley is also an inventor on over 50 patents and a founder of three companies, GeneOhm Sciences (acquired by Becton Dickinson in 2005), Xagenic Inc. (acquired by General Atomics in 2017), and Cellular Analytics.
EDITOR’S NOTE: This article was adapted from a piece on the Weinberg College of Arts and Sciences website. You can read the full story here.